Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 High cases of cancer
4.1.2 Increasing investments
4.1.3 Various applications
4.2 Restraints
4.2.1Lack of reimbursement
4.3 Opportunities
4.3.1 Emerging markets offer profitable opportunities
4.4 Challenges
4.4.1.Complexities in gene structure.
Chapter 5 South America Epigenetic Market - By Product
5.1 Reagents
5.2Kits
5.3Enzymes
5.4 Instruments
Chapter 6 South America Epigenetic Market - By Technology
6.1 RNA Interference
6.2 DNA Methylation
6.3 Histone Modifications
Chapter 7 South America Epigenetic Market - By End-User
7.1 Pharmaceutical
7.2 Biotechnology
7.3 Contract Research Organisation.
Chapter 8 South America Epigenetic Market - By Geography
8.1 Introduction
8.2South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
Chapter 9South America Epigenetic Market - Company Profiles
9.1.Cellcentric
9.2.Gilead Sciences Inc.
9.3.Illumina Inc.
9.4.Novartis AG
9.5. Epiontis
9.6.Karus Therapeutics
9.7.Diagenode
9.8.Ribimed Biotechnologies
9.9.Covaris Inc.
9.10.Eisai Co. Ltd.
9.11.Celgene
9.12.Qiagen AG
9.13.Merck Millipore
9.14.Epizyme
9.15 4SC
Chapter 10 South America Epigenetic Market - Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
